{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:57:28Z","timestamp":1740149848419,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12328-024-02036-4","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T19:02:18Z","timestamp":1726081338000},"page":"1003-1008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful novel use of dupilumab for gastrointestinal involvement of idiopathic hypereosinophilic syndrome: case report and review of the literature"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2794-9956","authenticated-orcid":false,"given":"Clare","family":"Moffatt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy A.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"2036_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ajh.26352","volume":"97","author":"W Shomali","year":"2022","unstructured":"Shomali W, Gotlib J. World health organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97:129\u201348.","journal-title":"Am J Hematol"},{"key":"2036_CR2","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","volume":"124","author":"PU Ogbogu","year":"2009","unstructured":"Ogbogu PU, Bochner BS, Butterfield JH, et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol. 2009;124:1319-1325.e3.","journal-title":"J Allergy Clin Immunol"},{"key":"2036_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12016-018-8695-y","volume":"57","author":"VC Nanagas","year":"2019","unstructured":"Nanagas VC, Kovalszki A. Gastrointestinal manifestations of hypereosinophilic syndromes and mast cell disorders: a comprehensive review. Clinic Rev Allerg Immunol. 2019;57:194\u2013212.","journal-title":"Clinic Rev Allerg Immunol"},{"key":"2036_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jdcr.2020.02.030","volume":"6","author":"JK Wieser","year":"2020","unstructured":"Wieser JK, Kuehn GJ, Prezzano JC, et al. Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatment. JAAD Case Reports. 2020;6:292\u20135.","journal-title":"JAAD Case Reports"},{"key":"2036_CR5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00011-023-01715-1","volume":"72","author":"X Jiang","year":"2023","unstructured":"Jiang X, Ye J, Wu X, et al. A case of complete recovery in a hypereosinophilic dermatitis patient with dupilumab. Inflamm Res. 2023;72:875\u20138.","journal-title":"Inflamm Res"},{"key":"2036_CR6","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/gut.48.5.642","volume":"48","author":"C Cuffari","year":"2001","unstructured":"Cuffari C, Hunt S, Bayless T. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease. Gut. 2001;48:642\u20136.","journal-title":"Gut"},{"key":"2036_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11894-021-00809-2","volume":"23","author":"PH Chen","year":"2021","unstructured":"Chen PH, Anderson L, Zhang K, et al. Eosinophilic gastritis\/gastroenteritis. Curr Gastroenterol Rep. 2021;23:13.","journal-title":"Curr Gastroenterol Rep"},{"key":"2036_CR8","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jaip.2022.02.037","volume":"10","author":"FL Kuang","year":"2022","unstructured":"Kuang FL, De Melo MS, Makiya M, et al. Benralizumab completely depletes gastrointestinal tissue eosinophils and improves symptoms in eosinophilic gastrointestinal disease. J Allergy Clin Immunol Pract. 2022;10:1598-1605.e2.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2036_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/gut.2009.178558","volume":"59","author":"A Straumann","year":"2010","unstructured":"Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut. 2010;59:21\u201330.","journal-title":"Gut"},{"key":"2036_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jaci.2010.04.029","volume":"126","author":"S Conus","year":"2010","unstructured":"Conus S, Straumann A, Bettler E, et al. Mepolizumab does not alter levels of eosinophils, T cells, and mast cells in the duodenal mucosa in eosinophilic esophagitis. J Allergy Clin Immunol. 2010;126:175\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"2036_CR11","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jaci.2022.05.024","volume":"150","author":"A Akenroye","year":"2022","unstructured":"Akenroye A, Lassiter G, Jackson JW, et al. Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: a bayesian network meta-analysis. J Allergy Clin Immunol. 2022;150:1097-1105.e12.","journal-title":"J Allergy Clin Immunol"},{"key":"2036_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.anai.2022.11.004","volume":"130","author":"M Greenhawt","year":"2023","unstructured":"Greenhawt M. Biologics in eosinophilic gastrointestinal disease treatment: a new frontier. Ann Allergy Asthma Immunol. 2023;130:155\u20136.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2036_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2019.07.074","volume":"82","author":"M Deleuran","year":"2020","unstructured":"Deleuran M, Tha\u00e7i D, Beck LA, et al. Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study. J Am Acad Dermatol. 2020;82:377\u201388.","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02036-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-024-02036-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02036-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T08:24:01Z","timestamp":1731054241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-024-02036-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["2036"],"URL":"https:\/\/doi.org\/10.1007\/s12328-024-02036-4","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed patient consent was obtained for publication of the case details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}